Karen Kaplan
Concepts (308)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Thrombin | 17 | 1974 | 42 |
Why?
| Blood Platelets | 26 | 1974 | 68 |
Why?
| Fibrinogen | 16 | 1976 | 45 |
Why?
| Fibrin | 10 | 1979 | 23 |
Why?
| Platelet Factor 4 | 15 | 1978 | 10 |
Why?
| Anticoagulants | 5 | 1999 | 88 |
Why?
| Arteriosclerosis | 5 | 1981 | 54 |
Why?
| Beta-Globulins | 7 | 1978 | 5 |
Why?
| Thrombosis | 7 | 1978 | 105 |
Why?
| Platelet Aggregation | 13 | 1974 | 33 |
Why?
| Hirudins | 2 | 2003 | 9 |
Why?
| beta-Thromboglobulin | 10 | 1980 | 1 |
Why?
| Carotid Artery, Internal | 1 | 2006 | 27 |
Why?
| Heparin | 5 | 1978 | 87 |
Why?
| Platelet Activation | 1 | 2006 | 18 |
Why?
| Carotid Stenosis | 1 | 2006 | 33 |
Why?
| Blood Coagulation Factors | 8 | 1978 | 31 |
Why?
| Antithrombins | 1 | 2003 | 2 |
Why?
| Pipecolic Acids | 1 | 2003 | 2 |
Why?
| Thrombocytopenia | 2 | 1999 | 46 |
Why?
| Myocardial Infarction | 5 | 1980 | 129 |
Why?
| Peptide Fragments | 2 | 1986 | 145 |
Why?
| Thrombolytic Therapy | 1 | 2002 | 43 |
Why?
| Recombinant Proteins | 2 | 2003 | 290 |
Why?
| Venous Thrombosis | 5 | 2003 | 45 |
Why?
| Blood Coagulation Disorders | 2 | 1979 | 18 |
Why?
| Endothelium, Vascular | 5 | 1989 | 139 |
Why?
| Humans | 57 | 1974 | 1858 |
Why?
| Sepsis | 1 | 2000 | 73 |
Why?
| Fibrinopeptide A | 10 | 1976 | 4 |
Why?
| Testicular Neoplasms | 2 | 1998 | 26 |
Why?
| Antigens | 4 | 1979 | 66 |
Why?
| Leukemia, Plasma Cell | 1 | 1998 | 3 |
Why?
| Brain | 1 | 2006 | 305 |
Why?
| Meningeal Neoplasms | 1 | 1998 | 30 |
Why?
| Multiple Myeloma | 1 | 1998 | 44 |
Why?
| Blood Coagulation | 3 | 1987 | 57 |
Why?
| Coronary Disease | 6 | 1980 | 94 |
Why?
| Fibrin Fibrinogen Degradation Products | 4 | 1979 | 16 |
Why?
| Brain Neoplasms | 1 | 1998 | 116 |
Why?
| Antibodies, Monoclonal | 4 | 1983 | 242 |
Why?
| Catheterization | 2 | 1986 | 47 |
Why?
| Cytoplasmic Granules | 8 | 1979 | 30 |
Why?
| Lung Diseases | 2 | 1985 | 112 |
Why?
| Collagen | 6 | 1974 | 119 |
Why?
| Epoprostenol | 2 | 1984 | 9 |
Why?
| Adenosine Diphosphate | 6 | 1974 | 30 |
Why?
| Serum Globulins | 2 | 1979 | 7 |
Why?
| Contrast Media | 1 | 1991 | 116 |
Why?
| Pulmonary Embolism | 3 | 2003 | 48 |
Why?
| Blood Coagulation Tests | 3 | 1991 | 33 |
Why?
| Blood Vessels | 1 | 1990 | 65 |
Why?
| Tissue Plasminogen Activator | 1 | 1989 | 32 |
Why?
| Epinephrine | 4 | 1974 | 53 |
Why?
| Umbilical Veins | 2 | 1983 | 46 |
Why?
| Male | 17 | 1978 | 1558 |
Why?
| Vena Cava, Inferior | 2 | 2003 | 26 |
Why?
| Blood Circulation | 1 | 1987 | 26 |
Why?
| Growth Substances | 4 | 1978 | 51 |
Why?
| P-Selectin | 1 | 2006 | 20 |
Why?
| Fibrinolytic Agents | 1 | 1987 | 43 |
Why?
| Treatment Outcome | 3 | 2002 | 662 |
Why?
| Female | 15 | 1979 | 1646 |
Why?
| Blood Proteins | 2 | 1983 | 71 |
Why?
| Serotonin | 8 | 1974 | 44 |
Why?
| Albinism | 1 | 1985 | 6 |
Why?
| Blood Platelet Disorders | 1 | 1985 | 5 |
Why?
| Muscle, Smooth, Vascular | 1 | 1990 | 59 |
Why?
| Lymphoma, B-Cell | 1 | 2006 | 33 |
Why?
| Cerebrovascular Circulation | 1 | 2006 | 62 |
Why?
| Lymphoma, Large B-Cell, Diffuse | 1 | 2006 | 38 |
Why?
| Granuloma, Respiratory Tract | 1 | 2004 | 2 |
Why?
| Radioimmunoassay | 6 | 1978 | 82 |
Why?
| Terminology as Topic | 1 | 1985 | 81 |
Why?
| Pulmonary Fibrosis | 1 | 1985 | 49 |
Why?
| Nicardipine | 1 | 2004 | 6 |
Why?
| Hypotension, Controlled | 1 | 2004 | 7 |
Why?
| Nitroprusside | 1 | 2004 | 24 |
Why?
| Filtration | 1 | 2003 | 27 |
Why?
| Vena Cava Filters | 1 | 2003 | 8 |
Why?
| Immunoenzyme Techniques | 4 | 1983 | 125 |
Why?
| Vasodilator Agents | 1 | 2004 | 56 |
Why?
| Autoimmune Diseases | 1 | 2004 | 49 |
Why?
| Metabolic Clearance Rate | 1 | 2003 | 31 |
Why?
| Scoliosis | 1 | 2004 | 20 |
Why?
| Antigens, Surface | 1 | 1983 | 51 |
Why?
| Hemolytic-Uremic Syndrome | 1 | 2003 | 6 |
Why?
| Half-Life | 1 | 2003 | 69 |
Why?
| Coronary Vessels | 3 | 1986 | 53 |
Why?
| Middle Aged | 11 | 1978 | 1166 |
Why?
| Diabetic Angiopathies | 1 | 2003 | 24 |
Why?
| Bone Marrow | 2 | 1989 | 109 |
Why?
| Retrospective Studies | 3 | 2002 | 656 |
Why?
| Arachidonic Acids | 4 | 1979 | 14 |
Why?
| Lysophosphatidylcholines | 1 | 1981 | 25 |
Why?
| Aorta | 3 | 1984 | 69 |
Why?
| Adult | 13 | 1978 | 1321 |
Why?
| Kidney Transplantation | 1 | 2003 | 66 |
Why?
| Hypergammaglobulinemia | 1 | 1980 | 5 |
Why?
| Thrombocythemia, Essential | 1 | 1980 | 6 |
Why?
| Animals | 11 | 1974 | 1032 |
Why?
| Proportional Hazards Models | 1 | 2002 | 123 |
Why?
| Complement Activation | 1 | 2000 | 13 |
Why?
| APACHE | 1 | 2000 | 18 |
Why?
| Multivariate Analysis | 1 | 2002 | 227 |
Why?
| Sex Factors | 1 | 2002 | 286 |
Why?
| Molecular Weight | 4 | 1978 | 155 |
Why?
| Factor VIII | 1 | 1979 | 28 |
Why?
| Age Factors | 1 | 2002 | 480 |
Why?
| Chromatography, Gel | 4 | 1979 | 61 |
Why?
| Immunoglobulin G | 1 | 1980 | 192 |
Why?
| China | 1 | 1998 | 35 |
Why?
| Fibrinolysin | 2 | 1986 | 9 |
Why?
| Pregnancy | 4 | 1979 | 457 |
Why?
| Concanavalin A | 1 | 1975 | 25 |
Why?
| Aged | 6 | 1978 | 992 |
Why?
| Cytokines | 1 | 2000 | 207 |
Why?
| Severity of Illness Index | 1 | 2000 | 359 |
Why?
| Platelet Adhesiveness | 1 | 1974 | 8 |
Why?
| Calcium | 5 | 1979 | 210 |
Why?
| Fibrinopeptide B | 5 | 1976 | 2 |
Why?
| Dose-Response Relationship, Drug | 4 | 1978 | 431 |
Why?
| Thromboxane A2 | 2 | 1981 | 11 |
Why?
| Antibodies | 1 | 1974 | 159 |
Why?
| Endotoxins | 2 | 1984 | 35 |
Why?
| Cells, Cultured | 5 | 1978 | 447 |
Why?
| Kinetics | 3 | 1979 | 349 |
Why?
| Goats | 2 | 1982 | 17 |
Why?
| Liver | 1 | 1998 | 249 |
Why?
| Hyperlipidemias | 2 | 1980 | 42 |
Why?
| Cycloheximide | 2 | 1989 | 51 |
Why?
| Thromboplastin | 3 | 1978 | 21 |
Why?
| Cerebrovascular Disorders | 2 | 1980 | 66 |
Why?
| Arterial Occlusive Diseases | 2 | 1980 | 36 |
Why?
| Cytochalasins | 2 | 1984 | 2 |
Why?
| Trifluoperazine | 2 | 1984 | 7 |
Why?
| Cytochalasin D | 2 | 1984 | 16 |
Why?
| Specimen Handling | 2 | 1982 | 52 |
Why?
| Vinblastine | 2 | 1984 | 22 |
Why?
| Magnetic Resonance Imaging | 1 | 1998 | 295 |
Why?
| Thrombophlebitis | 2 | 1980 | 23 |
Why?
| Kidney Diseases | 2 | 1980 | 90 |
Why?
| Vascular Diseases | 2 | 1982 | 60 |
Why?
| Disseminated Intravascular Coagulation | 2 | 1980 | 10 |
Why?
| Prognosis | 2 | 2003 | 389 |
Why?
| Saline Solution, Hypertonic | 2 | 1979 | 12 |
Why?
| Abortion, Induced | 2 | 1979 | 26 |
Why?
| Indomethacin | 2 | 1979 | 43 |
Why?
| Fatty Acids, Monounsaturated | 1 | 1990 | 6 |
Why?
| Escherichia coli | 2 | 1984 | 143 |
Why?
| Interleukin-1 | 1 | 1991 | 109 |
Why?
| Dietary Fats | 1 | 1990 | 33 |
Why?
| Adenocarcinoma | 2 | 1983 | 167 |
Why?
| Kidney Glomerulus | 1 | 1989 | 19 |
Why?
| Thromboembolism | 3 | 1978 | 27 |
Why?
| Immune Sera | 1 | 1989 | 56 |
Why?
| Glycoproteins | 2 | 1974 | 113 |
Why?
| Cholesterol | 1 | 1990 | 86 |
Why?
| Cross Reactions | 1 | 1989 | 65 |
Why?
| 6-Ketoprostaglandin F1 alpha | 1 | 1989 | 9 |
Why?
| Immunochemistry | 1 | 1989 | 10 |
Why?
| Antibody Specificity | 1 | 1989 | 71 |
Why?
| Aspirin | 2 | 1979 | 50 |
Why?
| Streptokinase | 2 | 1979 | 18 |
Why?
| Dactinomycin | 1 | 1989 | 40 |
Why?
| Histocytochemistry | 1 | 1989 | 65 |
Why?
| Femoral Artery | 1 | 1989 | 52 |
Why?
| Catecholamines | 2 | 1983 | 40 |
Why?
| Tissue Distribution | 1 | 1989 | 124 |
Why?
| Exercise Test | 2 | 1983 | 51 |
Why?
| Placenta | 1 | 1989 | 48 |
Why?
| Arachidonic Acid | 2 | 1982 | 29 |
Why?
| Partial Thromboplastin Time | 1 | 1987 | 15 |
Why?
| Endothelium | 2 | 1983 | 38 |
Why?
| Reference Values | 2 | 1981 | 281 |
Why?
| Clinical Laboratory Techniques | 1 | 1987 | 31 |
Why?
| Urokinase-Type Plasminogen Activator | 1 | 1987 | 38 |
Why?
| Infusions, Intravenous | 1 | 1987 | 87 |
Why?
| Membrane Proteins | 1 | 1991 | 233 |
Why?
| Biocompatible Materials | 1 | 1987 | 33 |
Why?
| Angina, Unstable | 1 | 1986 | 20 |
Why?
| Bleeding Time | 1 | 1985 | 10 |
Why?
| Thrombospondins | 1 | 1985 | 5 |
Why?
| Chemistry, Physical | 1 | 1985 | 25 |
Why?
| Physicochemical Phenomena | 1 | 1985 | 26 |
Why?
| Lung | 3 | 1978 | 233 |
Why?
| Colonic Diseases | 1 | 1985 | 19 |
Why?
| Risk | 1 | 2006 | 203 |
Why?
| Immunohistochemistry | 1 | 1989 | 356 |
Why?
| Renal Dialysis | 1 | 1986 | 56 |
Why?
| Syndrome | 1 | 1985 | 142 |
Why?
| Lupus Coagulation Inhibitor | 1 | 2004 | 5 |
Why?
| Neoplasms, Unknown Primary | 1 | 2004 | 4 |
Why?
| Platelet-Derived Growth Factor | 1 | 1985 | 37 |
Why?
| Vitamin E | 1 | 1985 | 38 |
Why?
| Hepatitis C, Chronic | 1 | 2004 | 10 |
Why?
| Inflammatory Bowel Diseases | 1 | 2004 | 11 |
Why?
| Portal Vein | 1 | 2004 | 30 |
Why?
| Platelet Count | 1 | 2004 | 39 |
Why?
| Recurrence | 2 | 1978 | 261 |
Why?
| Blood Loss, Surgical | 1 | 2004 | 28 |
Why?
| Cattle | 2 | 1981 | 176 |
Why?
| Avidin | 1 | 1983 | 4 |
Why?
| Cell Adhesion | 2 | 1981 | 113 |
Why?
| Drug Resistance | 1 | 2004 | 83 |
Why?
| Biotin | 1 | 1983 | 14 |
Why?
| Heparin, Low-Molecular-Weight | 1 | 2004 | 11 |
Why?
| Warfarin | 1 | 2004 | 27 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2004 | 49 |
Why?
| Spinal Fusion | 1 | 2004 | 24 |
Why?
| Pancreas Transplantation | 1 | 2003 | 9 |
Why?
| Phosphatidic Acids | 1 | 1982 | 3 |
Why?
| Peptides | 1 | 1985 | 154 |
Why?
| Physical Exertion | 1 | 1983 | 46 |
Why?
| Cadaver | 1 | 2003 | 51 |
Why?
| Phosphatidylinositols | 1 | 1982 | 17 |
Why?
| Cell Membrane | 2 | 1974 | 170 |
Why?
| Acute Kidney Injury | 1 | 2003 | 34 |
Why?
| Tissue Donors | 1 | 2003 | 41 |
Why?
| Cell Separation | 1 | 1983 | 110 |
Why?
| Drug Administration Schedule | 1 | 2003 | 193 |
Why?
| Electrophoresis, Polyacrylamide Gel | 2 | 1978 | 168 |
Why?
| Hypertension | 1 | 1986 | 161 |
Why?
| Phosphocreatine | 1 | 1981 | 11 |
Why?
| Living Donors | 1 | 2003 | 27 |
Why?
| Apyrase | 1 | 1981 | 12 |
Why?
| Prospective Studies | 1 | 1987 | 547 |
Why?
| Carcinoma | 1 | 2003 | 109 |
Why?
| Creatine Kinase | 1 | 1981 | 37 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 1983 | 224 |
Why?
| Blood Pressure | 1 | 2004 | 205 |
Why?
| Platelet Activating Factor | 1 | 1981 | 18 |
Why?
| Serum Albumin | 1 | 1981 | 55 |
Why?
| Drug Synergism | 1 | 1981 | 104 |
Why?
| Heart Rate | 1 | 2004 | 138 |
Why?
| Adenosine Triphosphate | 2 | 1979 | 121 |
Why?
| Adenosine Monophosphate | 1 | 1980 | 14 |
Why?
| Purpura, Thrombocytopenic | 1 | 1980 | 11 |
Why?
| Evaluation Studies as Topic | 1 | 1981 | 178 |
Why?
| Immunoglobulin Fab Fragments | 2 | 1974 | 23 |
Why?
| Blood Specimen Collection | 1 | 1980 | 17 |
Why?
| Globulins | 1 | 1979 | 3 |
Why?
| Heart Valve Prosthesis | 1 | 1980 | 23 |
Why?
| Cell Fractionation | 1 | 1979 | 42 |
Why?
| Cell Compartmentation | 1 | 1979 | 37 |
Why?
| Lupus Erythematosus, Systemic | 1 | 1980 | 53 |
Why?
| Binding, Competitive | 1 | 1979 | 109 |
Why?
| Oxygenases | 1 | 1979 | 10 |
Why?
| Sodium Chloride | 1 | 1979 | 77 |
Why?
| Aged, 80 and over | 1 | 2006 | 602 |
Why?
| Subcellular Fractions | 1 | 1979 | 67 |
Why?
| Time Factors | 3 | 1978 | 896 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 121 |
Why?
| Diabetes Mellitus | 1 | 1980 | 73 |
Why?
| Rabbits | 2 | 1974 | 254 |
Why?
| Immunoassay | 1 | 1978 | 33 |
Why?
| Arteries | 1 | 1978 | 56 |
Why?
| Adolescent | 2 | 1983 | 892 |
Why?
| Muscle, Smooth | 1 | 1978 | 69 |
Why?
| Breast Neoplasms | 1 | 1983 | 186 |
Why?
| Protein Binding | 1 | 1979 | 256 |
Why?
| Platelet Factor 3 | 1 | 1975 | 1 |
Why?
| Methylmannosides | 1 | 1975 | 2 |
Why?
| Agglutination | 1 | 1975 | 8 |
Why?
| Depression, Chemical | 1 | 1975 | 41 |
Why?
| Trypsin | 1 | 1975 | 63 |
Why?
| von Willebrand Factor | 1 | 1995 | 34 |
Why?
| Carbon Radioisotopes | 1 | 1974 | 43 |
Why?
| Mice | 2 | 1978 | 623 |
Why?
| Triglycerides | 1 | 1990 | 48 |
Why?
| Random Allocation | 1 | 1990 | 160 |
Why?
| Cholesterol, HDL | 1 | 1990 | 26 |
Why?
| Cholesterol, LDL | 1 | 1990 | 23 |
Why?
| Cell Survival | 1 | 1991 | 230 |
Why?
| Factor X | 1 | 1986 | 9 |
Why?
| Antigen-Antibody Complex | 1 | 1986 | 34 |
Why?
| Macromolecular Substances | 1 | 1986 | 92 |
Why?
| Cytochalasin B | 1 | 1984 | 12 |
Why?
| Colchicine | 1 | 1984 | 22 |
Why?
| Phospholipases A | 1 | 1984 | 24 |
Why?
| Clone Cells | 1 | 1984 | 92 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1984 | 83 |
Why?
| Thromboxane B2 | 1 | 1983 | 14 |
Why?
| Renin | 1 | 1983 | 26 |
Why?
| Hexosaminidases | 1 | 1982 | 6 |
Why?
| Antimycin A | 1 | 1982 | 10 |
Why?
| beta-N-Acetylhexosaminidases | 1 | 1982 | 5 |
Why?
| Deoxyglucose | 1 | 1982 | 17 |
Why?
| Glucuronidase | 1 | 1982 | 26 |
Why?
| Heart Aneurysm | 1 | 1982 | 12 |
Why?
| Leg | 1 | 1983 | 75 |
Why?
| Coronary Angiography | 1 | 1982 | 49 |
Why?
| Energy Metabolism | 1 | 1982 | 80 |
Why?
| Heart Ventricles | 1 | 1982 | 86 |
Why?
| Cross-Linking Reagents | 1 | 1980 | 38 |
Why?
| Infusions, Parenteral | 1 | 1979 | 38 |
Why?
| Temperature | 1 | 1980 | 137 |
Why?
| Fibrinolysis | 1 | 1979 | 17 |
Why?
| Uterus | 1 | 1979 | 49 |
Why?
| Thermodynamics | 1 | 1980 | 45 |
Why?
| Genetic Variation | 1 | 1979 | 92 |
Why?
| Fatty Acids | 1 | 1979 | 48 |
Why?
| Structure-Activity Relationship | 1 | 1979 | 124 |
Why?
| Stimulation, Chemical | 1 | 1978 | 42 |
Why?
| Postoperative Complications | 1 | 1983 | 306 |
Why?
| Mitochondria | 1 | 1979 | 101 |
Why?
| Cell Division | 1 | 1978 | 273 |
Why?
| Fibroblasts | 1 | 1978 | 179 |
Why?
|
|
Kaplan's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
